John C Thomas

CIK 1424620 · CFO and Secretary · last filed 2025-07-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$657.1K

Companies

7

Total Filings

42

Lifetime Open-Market Net

-$1.91M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DWTX Director $1.54 $0 2 2025-07-01
Dogwood Therapeutics, Inc. (VIRI) Delisted Director 1,000 $3.88 $3.9K $5.7K 5 2024-02-28
ImmunityBio, Inc. (NK) Delisted Director 221,363 -$1.92M 19 2020-12-11
NOVELION THERAPEUTICS INC. (NVLN) Delisted Director $0 2 2018-08-13
Innoveren Scientific, Inc. (MDVXW) Delisted Director 109,960 $0 2 2017-11-01
QLTI Director 24,500 $26.82 $657.1K $0 7 2016-06-21
Midatech Pharma US Inc. (DARA) Delisted CFO and Secretary 325,609 $0 3 2012-05-17

Recent Filings · Page 5 of 5

42 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-02-16 Midatech Pharma US Inc. (DARA) Delisted Grant (A) $0 EDGAR
2008-09-11 Midatech Pharma US Inc. (DARA) Delisted Grant (A) $0 EDGAR
Showing 4142 of 42
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.